| Citation: |
LI Xiaoyu, HUANG Qing, WU Yumeng, HU Sheng. The Global Cancer Statistics Report in 2022: A Narrow Spectrum Summary and Outlook[J]. Cancer Research on Prevention and Treatment, 2024, 51(5): 307-312. DOI: 10.3971/j.issn.1000-8578.2024.24.0437
|
According to the global cancer statistics in 2022 updated by the International Agency for Research on Cancer (IARC), there were nearly 20 million new cases of cancer and 9.7 million deaths. Lung cancer was the most commonly diagnosed cancer, accounting for nearly 2.5 million new cases (12.4% of all global cancers), followed by female breast cancer (11.6%), colorectal cancer (9.6%), prostate cancer (7.3%), and stomach cancer (4.9%). Lung cancer was also the leading cause of cancer deaths, with an estimated 1.8 million deaths (18.7%), followed by colorectal cancer (9.3%), liver cancer (7.8%), female breast cancer (6.9%), and stomach cancer (6.8%). Population-based projections suggest that the number of new cancer cases will reach 35 million by 2050. Increasing the investment in prevention and control measures targeting key cancer risk factors, including smoking, obesity, and infections, could save many lives globally and bring significant economic and social returns to countries in the coming decades.
Competing interests: The author declares that she has no competing interests.
| [1] |
Frick C, Rumgay H, Vignat J, et al. Quantitative estimates of preventable and treatable deaths from 36 cancers worldwide: a population-based study[J]. Lancet Glob Health, 2023, 11(11): e1700-e1712. doi: 10.1016/S2214-109X(23)00406-0
|
| [2] |
Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024, 74(3): 229-263. doi: 10.3322/caac.21834
|
| [3] |
International Agency for Research on Cancer, World Health Organization. CANCER TODAY website updated with GLOBOCAN 2022 database version 1.0[DB/OL]. [2024-01-02]. https://gco.iarc.who.int/today/en/dataviz/treemap?mode=population.
|
| [4] |
Soerjomataram I, Bray F. Planning for tomorrow: global cancer incidence and the role of prevention 2020-2070[J]. Nat Rev Clin Oncol, 2021, 18(10): 663-672.
|
| [5] |
Wild CP, Weiderpass E, Stewart BW. Word Cancer Report: Cancer Research for Cancer Prevention[EB/OL]. https://publications.iarc.fr/Non-Series-Publications/World-Cancer-Reports/World-Cancer-Report-Cancer-Research-For-Cancer-Prevention-2020.
|
| [6] |
The ASCO Post Staff. GLOBOCAN 2020 Database Provides Latest Global Data on Cancer Burden, Cancer Deaths[DB/OL]. (2020-12-22)[2021-01-27]. https://ascopost.com/news/december-2020/globocan-2020-database-provides-latest-global-data-on-cancer-burden-cancer-deaths/.
|
| [7] |
Ahmedin J, Lindsey T, Isabelle S, et al. The Cancer Atlas[M/OL]. (2019-10-16). https://canceratlas.cancer.org/wp-content/uploads/2019/10/ACS_CA3_Book.pdf.
|
| 1. |
闻苗苗，于鸣，闫俊. 胃癌组织中调宁蛋白1和肿瘤泛素异肽酶1的表达与临床病理特征的关系. 实用临床医药杂志. 2025(02): 1-5+13 .
| |
| 2. |
孙小妮，曹晓红. 肺癌患者免疫检查点抑制剂相关不良事件的危险因素研究进展. 临床肺科杂志. 2025(03): 449-454 .
| |
| 3. |
刘汉云. 疏肝解郁汤治疗三阴性乳腺癌临床观察. 湖北中医杂志. 2025(03): 15-19 .
| |
| 4. |
黄丽娜，邢玉荣. 认知行为疗法在胃癌患者疾病进展恐惧中的应用. 航空航天医学杂志. 2025(03): 363-365 .
| |
| 5. |
彭慧斌，韩晓东，高小盼. 肺癌患者凝血功能指标变化情况及其与预后的相关性. 临床医学工程. 2024(08): 1025-1026 .
| |
| 6. |
吴倩倩，郑雨欣，阮彦，盛燕红，白奇峰，刘俊平. 基于超声和临床病理特征构建浸润性乳腺癌腋窝淋巴结高负荷的预测模型. 现代实用医学. 2024(08): 1018-1021 .
|
Figures(4)
This work is licensed under a Creative Commons Attribution 3.0 License.
Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: